Fungal cellular machinery

Fungal cellular machinery is a broad, collective term encompassing all the structural components and biochemical processes vital for the life and reproduction of a fungal cell. While not a single, discrete therapeutic target itself, its various unique elements, which are either absent or significantly different from those in human cells, serve as critical targets for antifungal drug development. These targets include the fungal cell wall, composed of polysaccharides like chitin, glucans, and mannoproteins, which provides structural integrity and protection. The fungal cell membrane, characterized by the presence of ergosterol instead of cholesterol, is another key target. Additionally, essential cellular functions such as nucleic acid synthesis (DNA and RNA), protein synthesis, and cell division pathways are exploited by antifungal agents. Drugs targeting these components aim to selectively disrupt fungal growth, compromise cellular integrity, and ultimately lead to fungal cell death, thereby treating fungal infections. However, the development and use of antifungal drugs face challenges including the emergence of drug resistance, potential toxicity to human cells due to similarities in eukaryotic cellular processes, and issues with drug bioavailability and interactions.

Other names

Fungal cell componentsFungal cellular processesFungal cell structures

Fungal cellular machinery refers to the entire collection of components and processes within a fungal cell. Antifungal drugs target specific elements of this machinery that are essential for fungal survival but are either absent or significantly different in human cells. Key mechanisms of action include: * **Cell Wall Disruption:** Echinocandins (e.g., Caspofungin, Micafungin, Anidulafungin, Rezafungin, Ibrexafungerp) inhibit β-(1,3)-D-glucan synthase, a crucial enzyme for cell wall synthesis, leading to osmotic fragility and cell lysis. Other potential targets in the cell wall include chitin synthesis and mannoprotein synthesis. * **Cell Membrane/Ergosterol Biosynthesis Inhibition:** Polyenes (e.g., Amphotericin B, Nystatin, Natamycin) bind to ergosterol, the primary sterol in fungal cell membranes, causing membrane disruption, increased permeability, and leakage of cytoplasmic contents. Azoles (e.g., Fluconazole, Itraconazole, Voriconazole, Posaconazole) inhibit lanosterol 14α-demethylase (CYP51), an enzyme in the ergosterol biosynthesis pathway, leading to ergosterol depletion and accumulation of toxic sterol precursors, which alters membrane stability and function. Allylamines and squalene epoxidase inhibitors (e.g., Terbinafine, Naftifine, Butenafine) target squalene epoxidase, another enzyme in the ergosterol pathway, resulting in ergosterol depletion and squalene accumulation. * **Nucleic Acid Synthesis Inhibition:** Flucytosine (5-fluorocytosine) is converted to 5-fluorouracil, which interferes with pyrimidine metabolism, RNA synthesis (causing premature chain termination), and DNA synthesis (by inhibiting thymidylate synthase). Orotomides (e.g., F901318/Olorofim) inhibit dihydroorotate dehydrogenase (DHODH), blocking pyrimidine synthesis. * **Protein Synthesis Inhibition:** Some compounds like Aspirochlorine and Trichothecenes (e.g., Trichodermin, Nivalenol, T-2 toxin, Verrucarin A) selectively inhibit fungal protein synthesis by affecting polypeptide chain initiation or elongation/termination. * **Microtubule/Cell Division Disruption:** Griseofulvin binds to tubulin, disrupting microtubule function and inhibiting fungal cell mitosis.